SCHEMBL8096433

SCHEMBL8096433

Cc1cccc(Nc2nc(-c3ccc(Cl)cc3)nc3ccccc23)c1

nearest known ligand 0.83

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 12/20 0.83
▸ MAPT P10636 5/20 0.83
▸ ABCB1 P08183 2/20 0.83
▸ SMN1; SMN2 Q16637 2/20 0.83
▸ PDE5A O76074 3/20 0.71
▸ MEN1 O00255 6/20 0.67
▸ KMT2A Q03164 6/20 0.67
▸ NTSR1 P30989 1/20 0.67
▸ KDM4E B2RXH2 1/20 0.65
▸ TP53 P04637 4/20 0.65
▸ GAA P10253 2/20 0.65
▸ POLB P06746 1/20 0.65
▸ LMNA P02545 1/20 0.61
▸ LATS1 O95835 1/20 0.61
▸ ABCC1 P33527 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22201579 0.86 ABCG2 (0.85) ABCG2MAPTABCB1SMN1; SMN2PDE5A
SCHEMBL8093527 0.86 ABCG2 (0.82) ABCG2MAPTPDE5AMEN1KMT2A
SCHEMBL8094111 0.85 MAPT (0.67) ABCG2MAPTABCB1SMN1; SMN2PDE5A
SCHEMBL13945465 0.83 MEN1 (0.82) ABCG2MAPTABCB1SMN1; SMN2PDE5A
SCHEMBL28092379 0.82 MAPT (0.69) ABCG2MAPTABCB1SMN1; SMN2PDE5A
SCHEMBL4867505 0.82 ABCG2 (1.00) ABCG2MAPTPDE5AMEN1KMT2A
SCHEMBL5531993 0.82 ABCG2 (0.89) ABCG2MAPTABCB1SMN1; SMN2PDE5A
SCHEMBL16404316 0.81 ABCG2 (0.74) ABCG2MAPTABCB1SMN1; SMN2PDE5A
SCHEMBL1064901 0.80 TGFBR1 (0.82) ABCG2MAPTABCB1SMN1; SMN2PDE5A
SCHEMBL16404340 0.79 ABCG2 (0.72) ABCG2MAPTABCB1SMN1; SMN2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009000085-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES USEFUL AS MODULATORS OF GATED ION CHANNELS PAINCEPTOR PHARMA CORPORATION (CA) 2008-12-31 — — WO disclosed
Send feedback